Clinilabs NY
New
- Messages
- 1
- Reaction score
- 0
- Points
- 0
Facing Challenges with Epilepsy?
Epilepsy affects approximately 50 million people worldwide. Around 25% to 30% have intractable epilepsy that does not respond to conventional antiepileptic drug treatments. In fact, some epileptics require multiple medications to control seizure activity with limited effect.
Clinilabs is seeking volunteers for a new research study that aims to improve seizure control in refractory epilepsy patients using only one investigational antiepileptic medicine. If you are interested, or know of somebody who may be interested, please contact Clinilabs at 212-994-4567.
Eligible volunteers may receive at no cost:
• Medical care
• Laboratory work
• Clinical evaluations
• Compensation for time and travel
Medical insurance is not necessary to participate.
Transportation can be provided.
Epilepsy affects approximately 50 million people worldwide. Around 25% to 30% have intractable epilepsy that does not respond to conventional antiepileptic drug treatments. In fact, some epileptics require multiple medications to control seizure activity with limited effect.
Clinilabs is seeking volunteers for a new research study that aims to improve seizure control in refractory epilepsy patients using only one investigational antiepileptic medicine. If you are interested, or know of somebody who may be interested, please contact Clinilabs at 212-994-4567.
Eligible volunteers may receive at no cost:
• Medical care
• Laboratory work
• Clinical evaluations
• Compensation for time and travel
Medical insurance is not necessary to participate.
Transportation can be provided.